ARCHIVES

FDA Approves Xtandi For Late-Stage Castration-Resistant Prostate Cancer

This article is from The Cancer Letter archive.

Vol. 35 No. 8 | August 31, 2012

Download PDF Visit The Full Archive

Related Articles

June issue of Business & Regulatory Report included.

July 2, 2004

FDA News: Rule Limits Drug Pioneers To 30-Month Patent Extension

June 20, 2003

Also MQSA should require mammography facilities to gather data on interpretation, cancer policy board committee says.

May 27, 2005

NCI Staff Will Recommend That Comprehensive Recognition Be Withdrawn From Colorado Center

October 31, 1980

ACS, SU2C Committ $20 Million For Lung Cancer Dream Team

January 31, 2014

Wittes, Group Chairmen Agree On Payment Per Case, Other Methods To Increase Patient Accrual

August 21, 1987